Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.
Leuk Res. 2018 Apr;67:21-26. doi: 10.1016/j.leukres.2018.01.022. Epub 2018 Jan 31.
Leuk Res. 2018.
PMID: 29407183
Free article.
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes.
Itzykson R, Crouch S, Travaglino E, Smith A, Symeonidis A, Hellström-Lindberg E, Sanz G, Čermák J, Stauder R, Elena C, Germing U, Mittelman M, Langemeijer S, Mądry K, Tatic A, Holm MS, Almeida AM, Savic A, Šimec NG, Luño E, Culligan D, Guerci-Bresler A, Malcovati L, van Marrewijk C, Bowen D, de Witte T, Fenaux P; European MDS Registry members.
Itzykson R, et al. Among authors: simec ng.
Blood Adv. 2018 Aug 28;2(16):2079-2089. doi: 10.1182/bloodadvances.2018020495.
Blood Adv. 2018.
PMID: 30126931
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Hoeks M, Yu G, Langemeijer S, Crouch S, de Swart L, Fenaux P, Symeonidis A, Čermák J, Hellström-Lindberg E, Sanz G, Stauder R, Holm MS, Mittelman M, Mądry K, Malcovati L, Tatic A, Almeida AM, Germing U, Savic A, Šimec NG, Culligan D, Itzykson R, Guerci-Bresler A, Slama B, Droste J, van Marrewijk C, van de Loosdrecht A, Blijlevens N, van Kraaij M, Bowen D, de Witte T, Smith A; EUMDS Registry Participants.
Hoeks M, et al. Among authors: simec ng.
Haematologica. 2020 Mar;105(3):640-651. doi: 10.3324/haematol.2018.212332. Epub 2019 Jul 5.
Haematologica. 2020.
PMID: 31278207
Free PMC article.
Item in Clipboard
[GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROME].
Šimec NG, Kaić G, Škrtić A, Šiftar Z, Lasan-Trčić R, Valković T, Puškarić BJ, Rogulj IM, Zatezalo V, Nemet D, Kolonić SO.
Šimec NG, et al.
Lijec Vjesn. 2017 Jan-Feb;139(1-2):1-11.
Lijec Vjesn. 2017.
PMID: 30148578
Croatian.
Item in Clipboard
[AUTOLOGOUS STEM CELL TRANSPLANTATION IN REFRACTORY OR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA - A SINGLE CENTRE EXPERIENCE].
Milunović V, Patekar MB, Roso V, Zatezalo V, Stipinović BA, Jakobac KM, Šimec NG, Radić-Krišto D, Planinc-Peraica A, Kolonić SO.
Milunović V, et al. Among authors: simec ng.
Lijec Vjesn. 2015 Sep-Oct;137(9-10):276-82.
Lijec Vjesn. 2015.
PMID: 26749949
Croatian.
Item in Clipboard
Successful long-term treatment with azacitidine in patient with chronic myelomonocytic leukemia.
Čemažar L, Podgornik H, Šimec NG, Zver S.
Čemažar L, et al. Among authors: simec ng.
Hematol Rep. 2020 Dec 2;12(3):8537. doi: 10.4081/hr.2020.8537. eCollection 2020 Dec 2.
Hematol Rep. 2020.
PMID: 33324479
Free PMC article.
Item in Clipboard
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group.
Lübbert M, et al.
Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9.
Lancet Haematol. 2023.
PMID: 37914482
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite